By Igor Kossov ( January 8, 2015, 4:30 PM EST) -- Alder BioPharmaceuticals Inc. said Thursday it had priced a follow-on offering of 6 million shares at $29.50 apiece, seeking to raise a total of $177 million to continue developing treatments for migraines and autoimmune and inflammatory diseases....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.